RxDoctor Payments Data

Jaclyn Price, DO

Family Medicine · Marion, IANPI 1417255340

Payments from drug & device makers

$975in general payments, 2019–2025

Across 64 payments — averaging $15.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$345
  • AbbVie$271
  • AstraZeneca$69
  • Johnson & Johnson$59
  • Abbott$37
  • Novo Nordisk$34
  • plus $161 from 8 others

What the payments were for

  • Food & beverage$975100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$975 in reported general payments places this provider in the 80th percentile of 1,357 family medicine providers in Iowa.

See all family medicine providers in Iowa

Medicare billing

Part B allowed, 2024
$121,364
Medicare patients
226
Services billed
2,656

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide91$123,279
MounjaroTirzepatide89$114,943
TrulicityDulaglutide50$59,417
JardianceEmpagliflozin39$46,548
Trelegy ElliptaFluticasone/Umeclidin/Vilanter45$44,327
XareltoRivaroxaban43$35,227
EliquisApixaban35$26,478
LinzessLinaclotide21$22,178
FarxigaDapagliflozin Propanediol23$17,756
JanuviaSitagliptin Phosphate15$17,334
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog12$16,893
MyrbetriqMirabegron22$14,842
Tresiba Flextouch U-100Insulin Degludec14$8,520
Lantus SolostarInsulin Glargine,hum.Rec.Anlog34$6,029
Arnuity ElliptaFluticasone Furoate17$4,481

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$15$174,360139 claims
Novo NordiskOzempic$34$123,27991 claims
GSKTrelegy Ellipta, Arnuity Ellipta$32$48,80862 claims
Johnson & JohnsonXarelto$59$35,22743 claims
PfizerEliquis$345$26,47835 claims
AbbVieLinzess, Synthroid$271$23,46948 claims
AstraZenecaFarxiga$69$17,75623 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,357 family medicine providers in Iowa.

Other family medicine in Marion

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →